Establishment of a hamster model for evaluation of cardiocytotoxic drugs (2008)
- Authors:
- Autor USP: GIDLUND, MAGNUS AKE - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Ribeirão Preto
- Date published: 2008
- Source:
- Título: Resumos
- Conference titles: Congress of the Brazilian Society for Immunology - SBI
-
ABNT
SANCHEZ, Eduardo Milton Ramos et al. Establishment of a hamster model for evaluation of cardiocytotoxic drugs. 2008, Anais.. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2008. . Acesso em: 20 mar. 2026. -
APA
Sanchez, E. M. R., Goto, H., Monteiro, A. M., Rodriguez, D. H., & Gidlund, M. A. (2008). Establishment of a hamster model for evaluation of cardiocytotoxic drugs. In Resumos. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Sanchez EMR, Goto H, Monteiro AM, Rodriguez DH, Gidlund MA. Establishment of a hamster model for evaluation of cardiocytotoxic drugs. Resumos. 2008 ;[citado 2026 mar. 20 ] -
Vancouver
Sanchez EMR, Goto H, Monteiro AM, Rodriguez DH, Gidlund MA. Establishment of a hamster model for evaluation of cardiocytotoxic drugs. Resumos. 2008 ;[citado 2026 mar. 20 ] - Opposing effects between short-term combined transdermal estradiol/noretisterone against oxidized LDL (oxLDL) and heat shock proteins (hsp)
- Influence of high density lipoprotein on the nitric oxide cell production after incubation of low density lipoprotein
- Backside-surface imprinting as a new strategy to generate specific plastic antibody materials
- Analysis of subclasses of rheumatoid factors (RF) and antibodies against oxidized low density lipoprotein in rheumatoid arthritis patients
- High-resolution separation of low-density lipoprotein (LDL) after oxidative (OXLDL) and enzymatic (ENZLDL) modifications: evaluation of antigenicity
- Characterization of native and oxidizedhuman low-density lipoproteins using a non-linear optical technique
- Coronary artery disease and Periodontitis: Is modified low density lipoprotein (mLDL) a contributing factor? Analysis of cytokines, anti-mLDL antibodies and Z-scan, a novel method to determine mLDL and LDL stability
- Opposing effects between short-termcombined transdermal estradiol/noretisterone and oral raloxifene treatment upon C-reactive protein and antibodies against oxidized LDL
- The nonlinear optical response of human native and oxidized LDL: a new method to quantify their amount in the plasma
- Análise de anticorpos contra Lipoproteína de baixa densidade (LDL) modificada e perfil de citocinas séricas. Novos marcadores para o processo aterosclerótico?
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
